NeutraHealth suspends shares
NeutraHealth has temporarily suspended trading of its shares on the AIM market. The Birmingham-based company is to make a further announcement clarifying its position.
The nutraceutical company was admitted to AIM on February 2005 and has been an active consolidator in its market, acquiring four businesses. Its latest share price was 6.5 pence per share.
In June 2010, it was announced that KBC Business Capital provided an £8m asset-based lending facility to support the refinancing of the senior debt facilities of NeutraHealth.
The financing was designed to enhance NeutraHealth’s working capital facilities and help to support the growth plans of the business, said KBC.
The facility comprised a mixture of accounts receivable, inventory and a cashflow loan.
